- Home
- ETON vs ZH Comparison
ETON vs ZH Comparison
Compare ETON & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- ZH
- Stock Information
- Founded
- ETON 2017
- ZH 2011
- Country
- ETON United States
- ZH China
- Employees
- ETON N/A
- ZH N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- ZH Business Services
- Sector
- ETON Health Care
- ZH Consumer Discretionary
- Exchange
- ETON Nasdaq
- ZH Nasdaq
- Market Cap
- ETON 428.5M
- ZH 352.6M
- IPO Year
- ETON 2018
- ZH 2021
- Fundamental
- Price
- ETON $13.75
- ZH $3.85
- Analyst Decision
- ETON Strong Buy
- ZH Strong Buy
- Analyst Count
- ETON 3
- ZH 1
- Target Price
- ETON $29.67
- ZH $4.70
- AVG Volume (30 Days)
- ETON 457.7K
- ZH 312.5K
- Earning Date
- ETON 08-07-2025
- ZH 08-21-2025
- Dividend Yield
- ETON N/A
- ZH N/A
- EPS Growth
- ETON N/A
- ZH N/A
- EPS
- ETON N/A
- ZH N/A
- Revenue
- ETON $48,327,000.00
- ZH $464,095,225.00
- Revenue This Year
- ETON $103.21
- ZH N/A
- Revenue Next Year
- ETON $51.34
- ZH $7.46
- P/E Ratio
- ETON N/A
- ZH N/A
- Revenue Growth
- ETON 40.88
- ZH N/A
- 52 Week Low
- ETON $3.19
- ZH $2.55
- 52 Week High
- ETON $21.48
- ZH $6.32
- Technical
- Relative Strength Index (RSI)
- ETON 26.60
- ZH 49.38
- Support Level
- ETON $13.09
- ZH $3.50
- Resistance Level
- ETON $14.18
- ZH $3.94
- Average True Range (ATR)
- ETON 0.78
- ZH 0.16
- MACD
- ETON -0.23
- ZH -0.00
- Stochastic Oscillator
- ETON 8.78
- ZH 53.03
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.